Cardiawave

company

About

Cardiawave is a medical device company .

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$8.20M
Industries
Collaboration,Health Care,Medical Device
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in ultrasound imaging and therapy, and the team at the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging.

Led by an experienced management team, 2017 Prizewinner of Worldwide Innovation Contest 3rd phase, Cardiawave has secured over €14m since inception, to develop its product and to pursue preclinical studies before first-in-man expected in 2019.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$8.20M €1.40M
Cardiawave has raised a total of $8.20M €1.40M in funding over 2 rounds. Their latest funding was raised on Sep 27, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 27, 2018 Series Unknown $8.20M 2 — — Detail
Mar 2, 2017 Series Unknown €1.40M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Cardiawave is funded by 2 investors. European program Instrument PME and Business Angels des Grandes Ecoles are the most recent investors.
Investor Name Lead Investor Funding Round
European program Instrument PME — Series Unknown
Business Angels des Grandes Ecoles — Series Unknown